Consistent with a previous study in this cohort (15), ex-vivo ELISPOT assays using peptide pools representing all four DENV serotypes detected overall low frequencies of IFNγ-secreting cells prior to symptomatic secondary infection and inconsistent increases in these responses after infection. The gene discussed is IFNG; the disease is infection.